Chronic Obstructive Pulmonary Disease therapy

View All

Chronic Obstructive Pulmonary Disease (COPD) Market Outlook
ATS 2023 Updates: Dupixent – A Ray of Hope For Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD)

DUPIXENT has shown positive pivotal results for COPD, confirming the key role of IL-4 and IL-13 in type 2 inflammatory diseases. DUPIXENT has the potential to be the first biologic with unprecedented and paradigm-shifting clinical results to treat COPD, having demonstrated a statistically significant reduc...

Find More

Chronic Obstructive Pulmonary Disease (COPD ) Treatment Market
Is Air Pollution a driver in COPD Treatment Market?

Levels of air pollution have risen dramatically over the past years due to increasing outdoor human activities such as industrialization, urbanization and indoor activities like burning of solid fuels, coal, etc. This has contaminated the air we breathe with several harmful substances such as Sulfur dioxide (SO2), ...

Find More